Pancytopenia in a Patient with Stevens-Johnson Syndrome: A Case Report with Literature Review

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare conditions triggered due to a medication that involves the necrosis and desquamation of the skin and mucous membranes. Only one out of 1,000,000 people are affected by the condition. The exact pathophysiology of the disease is still unknown. However, many complications of the disease can occur; pancytopenia and pleural effusion are an even rarer find. Here we present a case of a 17-year-old male who presented with fever and rash for 15 days associated with bleeding per rectum, hemoptysis, and conjunctival hemorrhages. Laboratory investigations showed severe pancytopenia, deranged liver function tests (LFTs), and hypocellular bone marrow. The patient started showing improvement after 10 days post-admission with supportive care and multiple transfusions.

[1]  H. Chandra,et al.  Clinico-hematological study of pancytopenia: A single-center experience from north Himalayan region of India , 2019, Journal of family medicine and primary care.

[2]  S. Austin,et al.  Bronchiolitis obliterans as a long‐term sequela of Stevens–Johnson syndrome and toxic epidermal necrolysis in children , 2019, Clinical and experimental dermatology.

[3]  D. Cook,et al.  A 10‐year retrospective cohort study of the management of toxic epidermal necrolysis and Stevens‐Johnson syndrome in a New South Wales state referral hospital from 2006 to 2016 , 2019, International journal of dermatology.

[4]  Abdul Rafae,et al.  Fecal Calprotectin as a Diagnostic and Prognostic Biomarker for Gastrointestinal Graft Versus Host Disease: A Systematic Review of Literature , 2019, Cureus.

[5]  B. Saka,et al.  Ocular and Mucocutaneous Sequelae among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Togo , 2019, Dermatology research and practice.

[6]  C. Caffarelli,et al.  Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis , 2019, Acta bio-medica : Atenei Parmensis.

[7]  T. Harr,et al.  Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis , 2018, Clinical Reviews in Allergy & Immunology.

[8]  Ju-Young Kim,et al.  Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea , 2016, PloS one.

[9]  S. Jariwala,et al.  O057 A case of Stevens-Johnson syndrome with thrombocytopenia , 2016 .

[10]  A. Papp,et al.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention. , 2016, The American journal of medicine.

[11]  H. Azukizawa.  Graft-Versus-Host Disease: A Model of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis , 2014 .

[12]  Zhidan Fan,et al.  Pancytopenia as an early indicator for Stevens-Johnson syndrome complicated with hemophagocytic lymphohistiocytosis: a case report , 2014, BMC Pediatrics.

[13]  W. Chung,et al.  Update on pathobiology in Stevens-Johnson syndrome and toxic epidermal necrolysis , 2013 .

[14]  Y. Tay,et al.  Hematological abnormalities and the use of granulocyte‐colony‐stimulating factor in patients with Stevens–Johnson syndrome and toxic epidermal necrolysis , 2011, International journal of dermatology.

[15]  G. Piérard,et al.  New Insights in Toxic Epidermal Necrolysis (Lyell’s Syndrome) , 2010, Drug safety.

[16]  M. Camilleri,et al.  Clinical, etiologic, and histopathologic features of Stevens-Johnson syndrome during an 8-year period at Mayo Clinic. , 2010, Mayo Clinic proceedings.

[17]  R. Aster,et al.  Drug‐induced immune thrombocytopenia: pathogenesis, diagnosis, and management , 2009, Journal of thrombosis and haemostasis : JTH.

[18]  Yuan-Tsong Chen,et al.  Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis , 2008, Nature Medicine.

[19]  O. Ibrahimi,et al.  Stevens‐Johnson syndrome: Pathogenesis, diagnosis, and management , 2008, Annals of medicine.

[20]  Lars E French,et al.  Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. , 2006, Allergology international : official journal of the Japanese Society of Allergology.